A Usability Study of iTEAR100 For Combined EyeLid Microblepharoexfoliation and Neurostimulation
Status unconfirmed · Phase 1
Conditions studied: MicroBlepharoexfoliation, NuLids, iTEAR100, iLIDS100, Blepharitis, Dry Eye Syndrome
In brief
The purpose of this study is to evaluate the usability of the iTEAR100 generation 2 device in combination with its newly developed iLIDS100 disposable cover.
Key facts
- Study ID
- NCT06235450
- Run by
- Olympic Ophthalmics, Inc.
- People needed
- 200
- Starts
- 2024-01-19
- Expected to finish
- 2025-12-31
- Last updated by the study team
- 2024-02-01
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Must use iTEAR and NuLids at time of enrollment
You may not qualify if…
- have any condition, which in the judgment of the PI would prevent a potential subject from safely completing the study or tolerating device use, such as mental illness, dementia, severe agitation, etc. and including inability to comply with the treatment regimen.
Where it is running
- Olympic Ophthalmics — Issaquah, Washington, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.